Additionally, treatment of colon cancer using oncolytic herpes simplex virus (oHSV) (O-HSV1211) modified to express both IL-12 and CXCL11 leads to increased infiltration of CD8+ T and CD4+ T cells into the tumor site (29). Here, CXCL11 is linked to neoplasm.